The Risk of Reintervention of the Mitroflow and Trifecta Bioprosthesis

Ann Thorac Surg. 2021 Aug;112(2):684-685. doi: 10.1016/j.athoracsur.2020.11.089. Epub 2021 Feb 22.

Authors

Ka Yan Lam¹, Naomi Timmermans², Mohamed Soliman-Hamad²

Affiliations

¹ Department of Cardiothoracic Surgery, Catharina Hospital, Michelangelolaan 2, PO Box 1350, 5602 ZA Eindhoven, The Netherlands. Electronic address: kayan.lam@catharinaziekenhuis.nl.
² Department of Cardiothoracic Surgery, Catharina Hospital, Michelangelolaan 2, PO Box 1350, 5602 ZA Eindhoven, The Netherlands.

PMID: 33631148
DOI: 10.1016/j.athoracsur.2020.11.089

No abstract available

Publication types

Letter
Comment

MeSH terms

Aortic Valve / diagnostic imaging
Aortic Valve / surgery
Bioprosthesis* / adverse effects
Heart Valve Prosthesis*
Humans